These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 36753562)
1. Hepatocytes demarcated by EphB2 contribute to the progression of nonalcoholic steatohepatitis. Xiao Y; Batmanov K; Hu W; Zhu K; Tom AY; Guan D; Jiang C; Cheng L; McCright SJ; Yang EC; Lanza MR; Liu Y; Hill DA; Lazar MA Sci Transl Med; 2023 Feb; 15(682):eadc9653. PubMed ID: 36753562 [TBL] [Abstract][Full Text] [Related]
2. Hepatocyte nuclear receptor SHP suppresses inflammation and fibrosis in a mouse model of nonalcoholic steatohepatitis. Zou A; Magee N; Deng F; Lehn S; Zhong C; Zhang Y J Biol Chem; 2018 Jun; 293(22):8656-8671. PubMed ID: 29666185 [TBL] [Abstract][Full Text] [Related]
3. Disruption of hepatic small heterodimer partner induces dissociation of steatosis and inflammation in experimental nonalcoholic steatohepatitis. Magee N; Zou A; Ghosh P; Ahamed F; Delker D; Zhang Y J Biol Chem; 2020 Jan; 295(4):994-1008. PubMed ID: 31831621 [TBL] [Abstract][Full Text] [Related]
4. Hepatocyte Notch activation induces liver fibrosis in nonalcoholic steatohepatitis. Zhu C; Kim K; Wang X; Bartolome A; Salomao M; Dongiovanni P; Meroni M; Graham MJ; Yates KP; Diehl AM; Schwabe RF; Tabas I; Valenti L; Lavine JE; Pajvani UB Sci Transl Med; 2018 Nov; 10(468):. PubMed ID: 30463916 [TBL] [Abstract][Full Text] [Related]
5. Hepatocyte TAZ/WWTR1 Promotes Inflammation and Fibrosis in Nonalcoholic Steatohepatitis. Wang X; Zheng Z; Caviglia JM; Corey KE; Herfel TM; Cai B; Masia R; Chung RT; Lefkowitch JH; Schwabe RF; Tabas I Cell Metab; 2016 Dec; 24(6):848-862. PubMed ID: 28068223 [TBL] [Abstract][Full Text] [Related]
6. CD11c+ resident macrophages drive hepatocyte death-triggered liver fibrosis in a murine model of nonalcoholic steatohepatitis. Itoh M; Suganami T; Kato H; Kanai S; Shirakawa I; Sakai T; Goto T; Asakawa M; Hidaka I; Sakugawa H; Ohnishi K; Komohara Y; Asano K; Sakaida I; Tanaka M; Ogawa Y JCI Insight; 2017 Nov; 2(22):. PubMed ID: 29202448 [TBL] [Abstract][Full Text] [Related]
8. A Functional Role of GAS6/TAM in Nonalcoholic Steatohepatitis Progression Implicates AXL as Therapeutic Target. Tutusaus A; de Gregorio E; Cucarull B; Cristóbal H; Aresté C; Graupera I; Coll M; Colell A; Gausdal G; Lorens JB; García de Frutos P; Morales A; Marí M Cell Mol Gastroenterol Hepatol; 2020; 9(3):349-368. PubMed ID: 31689560 [TBL] [Abstract][Full Text] [Related]
9. Cholesterol Induces Nrf-2- and HIF-1 Kaminsky-Kolesnikov Y; Rauchbach E; Abu-Halaka D; Hahn M; García-Ruiz C; Fernandez-Checa JC; Madar Z; Tirosh O Oxid Med Cell Longev; 2020; 2020():5393761. PubMed ID: 32566088 [TBL] [Abstract][Full Text] [Related]
10. The Annexin A2-Notch regulatory loop in hepatocytes promotes liver fibrosis in NAFLD by increasing osteopontin expression. Wang G; Duan J; Pu G; Ye C; Li Y; Xiu W; Xu J; Liu B; Zhu Y; Wang C Biochim Biophys Acta Mol Basis Dis; 2022 Aug; 1868(8):166413. PubMed ID: 35413401 [TBL] [Abstract][Full Text] [Related]
12. A TNFα/Miz1-positive feedback loop inhibits mitophagy in hepatocytes and propagates non-alcoholic steatohepatitis. Jin K; Shi Y; Zhang H; Zhangyuan G; Wang F; Li S; Chen C; Zhang J; Wang H; Zhang W; Sun B J Hepatol; 2023 Aug; 79(2):403-416. PubMed ID: 37040844 [TBL] [Abstract][Full Text] [Related]
14. Notch activity characterizes a common hepatocellular carcinoma subtype with unique molecular and clinicopathologic features. Zhu C; Ho YJ; Salomao MA; Dapito DH; Bartolome A; Schwabe RF; Lee JS; Lowe SW; Pajvani UB J Hepatol; 2021 Mar; 74(3):613-626. PubMed ID: 33038431 [TBL] [Abstract][Full Text] [Related]
15. Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice. Ganz M; Bukong TN; Csak T; Saha B; Park JK; Ambade A; Kodys K; Szabo G J Transl Med; 2015 Jun; 13():193. PubMed ID: 26077675 [TBL] [Abstract][Full Text] [Related]
16. The methyltransferase METTL3 negatively regulates nonalcoholic steatohepatitis (NASH) progression. Li X; Yuan B; Lu M; Wang Y; Ding N; Liu C; Gao M; Yao Z; Zhang S; Zhao Y; Xie L; Chen Z Nat Commun; 2021 Dec; 12(1):7213. PubMed ID: 34893641 [TBL] [Abstract][Full Text] [Related]
18. Inhibiting Interleukin 11 Signaling Reduces Hepatocyte Death and Liver Fibrosis, Inflammation, and Steatosis in Mouse Models of Nonalcoholic Steatohepatitis. Widjaja AA; Singh BK; Adami E; Viswanathan S; Dong J; D'Agostino GA; Ng B; Lim WW; Tan J; Paleja BS; Tripathi M; Lim SY; Shekeran SG; Chothani SP; Rabes A; Sombetzki M; Bruinstroop E; Min LP; Sinha RA; Albani S; Yen PM; Schafer S; Cook SA Gastroenterology; 2019 Sep; 157(3):777-792.e14. PubMed ID: 31078624 [TBL] [Abstract][Full Text] [Related]
19. Obeticholic acid protects against hepatocyte death and liver fibrosis in a murine model of nonalcoholic steatohepatitis. Goto T; Itoh M; Suganami T; Kanai S; Shirakawa I; Sakai T; Asakawa M; Yoneyama T; Kai T; Ogawa Y Sci Rep; 2018 May; 8(1):8157. PubMed ID: 29802399 [TBL] [Abstract][Full Text] [Related]
20. SLAMF1 is expressed and secreted by hepatocytes and the liver in nonalcoholic fatty liver disease. Gomez-Torres O; Amatya S; Kamberov L; Dhaibar HA; Khanna P; Rom O; Yurdagul A; Orr AW; Nunez K; Thevenot P; Cohen A; Samant H; Alexander JS; Burgos-Ramos E; Chapa-Rodriguez A; Cruz-Topete D Am J Physiol Gastrointest Liver Physiol; 2022 Sep; 323(3):G177-G187. PubMed ID: 35853010 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]